Effects of Dextrose on Knee Osteoarthritis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

106 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-31

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using double blind, randomized controlled design to study the immediate, short-term and intermediate-term therapeutic effects of ultrasound guided hyaluronic acid injection and hyaluronic acid combined dextrose injection to patients with knee osteoarthritis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Additional Effects of Steroid and Dextrose to Hyaluronic Acid on Knee Osteoarthritis

NCT04165902

Knee Osteoarthritis

UNKNOWN PHASE4

Effects of Knee Injections on Patients With Knee Osteoarthritis

NCT05220527

Knee Osteoarthritis Injection Effect of Drug

UNKNOWN PHASE4

Intraarticular Glucose Versus Hyaluronic Acid Injection for Knee Osteoarthrosis

NCT03690232

Osteoarthritis, Knee

UNKNOWN NA

Effects of Hyaluronic Acid vs. Hyaluronic Acid on Knee Osteoarthritis

NCT02625727

Physical Activity

UNKNOWN PHASE4

Changes in Cytokine Levels After Dextrose Injection in Stage IV Knee Osteoarthritis

NCT03400631

Osteoarthritis, Knee

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 106 patients will be collected. The participants will be randomized into two groups, including hyaluronic acid group and hyaluronic acid combined dextrose group.

The hyaluronic acid group will receive 3 times of hyaluronic acid injection per week in three weeks; the hyaluronic acid combined dextrose group will receive 3 times of hyaluronic acid combined dextrose injection per week in three weeks.

The pain, physical activity, and functional performance will be evaluated.

All the evaluations will be re-evaluated at one week after injection, one month after injection, three months after injection, and six month after injection.

Subjects and the evaluator will be both blinded to the group's classification during the whole course of study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Activity Functional Disturbance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hyaluronic acid combined dextrose group

Hyaluronic acid (2 cc) combined 25% dextrose (3.5 cc 50% dextrose plus 3.5 cc 2% lidocaine) injection: one injection per week, for 3 weeks, to compare the additional therapeutic effects of combined hyaluronic acid and dextrose injections to hyaluronic acid injections

Group Type ACTIVE_COMPARATOR